A simple question for your doctor to answer. How much is needed and how is it delivered? If not known, demand your doctor setup a clinical trial.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0059843
Abstract
Oxidative
damage plays a critical role in many diseases of the central nervous
system. This study was conducted to determine the molecular mechanisms
involved in the putative anti-oxidative effects of curcumin against
experimental stroke. Oxygen and glucose deprivation/reoxygenation
(OGD/R) was used to mimic ischemic insult in primary cultured cortical
neurons. A rapid increase in the intracellular expression of NAD(P)H:
quinone oxidoreductase1 (NQO1) induced by OGD was counteracted by
curcumin post-treatment, which paralleled attenuated cell injury. The
reduction of phosphorylation Akt induced by OGD was restored by
curcumin. Consequently, NQO1 expression and the binding activity of
nuclear factor-erythroid 2-related factor 2 (Nrf2) to antioxidant
response element (ARE) were increased. LY294002 blocked the increase in
phospho-Akt evoked by curcumin and abolished the associated protective
effect. Adult male Sprague-Dawley rats were subjected to transient
middle cerebral artery occlusion for 60 minutes.
Curcumin administration significantly reduced infarct size. Curcumin also markedly reduced
oxidative stress levels in middle cerebral artery occlusion (MCAO) rats;
hence, these effects were all suppressed by LY294002. Taken together,
these findings provide evidence that curcumin protects neurons against
ischemic injury, and this neuroprotective effect involves the Akt/Nrf2
pathway. In addition, Nrf2 is involved in the neuroprotective effects of
curcumin against oxidative damage.
No comments:
Post a Comment